Molecular study of the BRCA1 and BRCA2 genes in 153 breast cancer families from Castilla y León (Spain): New nine unclassified variants identified;Estudio molecular de los genes BRCA1 y BRCA2 en 153 familias con cáncer de mama de Castilla y León (España): Identificación de nueve variantes de efecto desconocido no descritas

Medicina Clinica

Volumn 119, Issue 12, 2002, Pages 441-445

  Velasco Sampedro, Eladio ^a   Esteban Cardeñosa, Eva ^a   Infante Sanz, Mar ^a   Durán Domínguez, Mercedes ^a   Lastra Aras, Enrique ^a   García Girón, Carlos ^a   Miner Pino, Cristina ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

BRCA1; BRCA2; Breast cancer; Mutation analysis; Polymorphism

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; GENOMIC DNA;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; FEMALE; FREQUENCY ANALYSIS; GEL ELECTROPHORESIS; GENE MUTATION; GENETIC DISORDER; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE BREAST; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; RISK ASSESSMENT; SPAIN;

EID: 17744421052     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7753(02)73450-7     Document Type: Article

References (28)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worlwide incidence of 25 major cancers in 1990. Int J Cancer 1999;80:827-41.
2. Moreno V, Sánchez V, Galcerán J, Borrás JM, Borrás J, Bosch FX. Riesgo de enfermar y morir por cáncer en Cataluña. Med Clin (Barc) 1998; 110:86-93.
3. Claus EB, Risch N, Thompson WD. Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 1991;48: 232-42.
4. Miki Y, Sweden J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266: 66-71.
5. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995; 378:789-92.
6. Easton DF, Ford D, Bishop DT, Breast Cancer Linkage Consortium. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genet 1995;56:265-71.
7. Couch FJ, Farid LM, DeShano ML, Tavtigian SV, Calzone K, Campeau L, et al. BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nat Genet 1996;13:123-5.
8. Szabo CI, King MC. Population genetics of BRCA1 and BRCA2. Am J Hum Genet 1997;60: 1013-20.
9. Schubert EL, Lee MK, Mefford HC, Argonza RH, Morrow JE, Hull J, et al. BRCA2 in American families with four or more cases of breast and ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2. Am J Hum Genet 1997;60: 1031-40.
10. Breast Cancer Information Core (BIC). Disponible en: http:www.nchgr.nih.gov/Intramural_research/Lab_transfer/Bic
11. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1998;62:676-89.
12. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidmann JG, Struhl K. DNAzol methodh. Current Protocols in Molecular Biology 1990;2 (Suppl A): 1-5.
13. Breast Cancer Information Core (BIC). Disponible en: http://www.nhgri.nih.gov/Intramural_research/Lab_transfer/ Bic/Member/index.html
14. Ganguly A, Rock MJ, Prockop DJ. Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: evidence for solvent-induced bends in DNA heteroduplexes. Proc Natl Acad Sci USA 1993;90:10325-9.
15. Vallon-Christersson J, Cayanan C, Haraldsson K, Loman N, Bergthorsson JT, Brondum-Nielsen K, et al. Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families. Hum Mol Genet 2001;10: 353-60.
16. Markoff A, Sormbroen H, Bogdanova N, Preisler-Adams S, Ganev V, Dworniczak B, et al. Comparison of conformation -sensitive gel electrophoresis and single-strand conformation polymorphism analysis for detection of mutations in the BRCA1 gene using optimized conformation analysis protocols. Eur J Hum Genet 1998;6: 145-50.
17. Gomendio B, Silva JM, García JM, Provencio M, España P, Bonilla F. Low Incidence of germline BRCA2 gene mutations among Spanish breast cancer patients. Oncology 1999;57:173-4.
18. Osorio A, Barroso A Martínez B, Cebrián A, San Román JM, Lobo F, et al. Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families. Br J Cancer 2000;82:1266-70.
19. Santarosa M, Dolcetti R, Magri MD, Crivellari D, Tibiletti MG, Gallo A, et al. BRCA1 and BRCA2 genes: role in hereditary breast and ovarian cancer in Italy. Int J Cancer 1999;83:5-9.
20. Ikeda N, Miyoshi Y, Yoneda K, Shiba E, Sekihara Y, Kinoshita M, et al. Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families. Int J Cancer 2001;91:83-8.
21. Osorio A, Robledo M, San Román JM, Albertos J, Andrade J, Barabash A, et al. Mutation analysis of the BRCA2 gene in breast/ovarian cancer Spanish families: identification of two new mutations. Cancer Letters 1997;121:115-8.
22. Neuhausen SL, Godwin AK, Gershoni-Baruch R, Schubert E, Garber J, Stoppa-Lyonnet D, et al. Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study. Am J Hum Genet 1998; 62:1381-8.
23. Serova O, Mazoyer S, Puget N, Dubois V, Tonin P, Shugart YY, et al. Mutations in BRCA1 and BRCA2 in breast cancer families: Are there more breast cancer susceptibility genes? Am J Hum Genet 1997;60:486-95.
24. Malone KE, Daling JR, Neal C, Suter NM, O'Brien C, Cushing-Haugen K, et al. Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases. Cancer 2000; 88:1393-402.
25. Diez Gibert O, Del Rio E, Doménech M, Hernández EM, Sanz J, Brunet J, et al. Mutaciones en el gen BRCA1 en mujeres españolas jóvenes con cáncer de mama. Med Clin (Barc) 1999;112:51-4.
26. Couch FJ, Farid LM, DeShano ML, Tavtigian SV, Calzone K, Campeau L, et al. BRCA2 germ-line mutations in male breast cancer cases and breast cancer families. Nature Genet 1996;13: 123-5.
27. Haraldsson K, Loman N, Zhang QX, Johannsson O, Olsson H, Borg A. BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the disease. Cancer Res 1998;58:1367-71.
28. Vega A, Campos B, Bressac-de-Paillerets B, Bond P, Janin N, Douglas F, et al. The R71G BRCA1 is a founder Spanish mutation and leads to aberrant splicing of the transcript. Hum Mutat 2001;17:520-1.